These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Evidence that Clostridium perfringens Enterotoxin-Induced Intestinal Damage and Enterotoxemic Death in Mice Can Occur Independently of Intestinal Caspase-3 Activation. Freedman JC; Navarro MA; Morrell E; Beingesser J; Shrestha A; McClane BA; Uzal FA Infect Immun; 2018 Jul; 86(7):. PubMed ID: 29685988 [No Abstract] [Full Text] [Related]
6. Fine mapping of the N-terminal cytotoxicity region of Clostridium perfringens enterotoxin by site-directed mutagenesis. Smedley JG; McClane BA Infect Immun; 2004 Dec; 72(12):6914-23. PubMed ID: 15557612 [TBL] [Abstract][Full Text] [Related]
7. RIP1, RIP3, and MLKL Contribute to Cell Death Caused by Clostridium perfringens Enterotoxin. Shrestha A; Mehdizadeh Gohari I; McClane BA mBio; 2019 Dec; 10(6):. PubMed ID: 31848291 [No Abstract] [Full Text] [Related]
8. Effects of Claudin-1 on the Action of Mehdizadeh Gohari I; Li J; Navarro M; Uzal F; McClane B Toxins (Basel); 2019 Oct; 11(10):. PubMed ID: 31601044 [No Abstract] [Full Text] [Related]
9. Deletion analysis of the Clostridium perfringens enterotoxin. Kokai-Kun JF; McClane BA Infect Immun; 1997 Mar; 65(3):1014-22. PubMed ID: 9038311 [TBL] [Abstract][Full Text] [Related]
10. Cysteine-scanning mutagenesis supports the importance of Clostridium perfringens enterotoxin amino acids 80 to 106 for membrane insertion and pore formation. Chen J; Theoret JR; Shrestha A; Smedley JG; McClane BA Infect Immun; 2012 Dec; 80(12):4078-88. PubMed ID: 22966051 [TBL] [Abstract][Full Text] [Related]
11. Development and application of a mouse intestinal loop model to study the in vivo action of Clostridium perfringens enterotoxin. Caserta JA; Robertson SL; Saputo J; Shrestha A; McClane BA; Uzal FA Infect Immun; 2011 Aug; 79(8):3020-7. PubMed ID: 21628512 [TBL] [Abstract][Full Text] [Related]
12. The VirS/VirR two-component system regulates the anaerobic cytotoxicity, intestinal pathogenicity, and enterotoxemic lethality of Clostridium perfringens type C isolate CN3685. Ma M; Vidal J; Saputo J; McClane BA; Uzal F mBio; 2011 Jan; 2(1):e00338-10. PubMed ID: 21264065 [TBL] [Abstract][Full Text] [Related]
13. Identification of a Clostridium perfringens enterotoxin region required for large complex formation and cytotoxicity by random mutagenesis. Kokai-Kun JF; Benton K; Wieckowski EU; McClane BA Infect Immun; 1999 Nov; 67(11):5634-41. PubMed ID: 10531210 [TBL] [Abstract][Full Text] [Related]
15. Identification of a prepore large-complex stage in the mechanism of action of Clostridium perfringens enterotoxin. Smedley JG; Uzal FA; McClane BA Infect Immun; 2007 May; 75(5):2381-90. PubMed ID: 17307943 [TBL] [Abstract][Full Text] [Related]
16. The Potential Therapeutic Agent Mepacrine Protects Caco-2 Cells against Freedman JC; Hendricks MR; McClane BA mSphere; 2017; 2(4):. PubMed ID: 28875177 [No Abstract] [Full Text] [Related]
17. In vitro cytotoxicity induced by Clostridium perfringens isolate carrying a chromosomal cpe gene is exclusively dependent on sporulation and enterotoxin production. Yasugi M; Sugahara Y; Hoshi H; Kondo K; Talukdar PK; Sarker MR; Yamamoto S; Kamata Y; Miyake M Microb Pathog; 2015 Aug; 85():1-10. PubMed ID: 25912832 [TBL] [Abstract][Full Text] [Related]
19. A synthetic peptide corresponding to the extracellular loop 2 region of claudin-4 protects against Clostridium perfringens enterotoxin in vitro and in vivo. Shrestha A; Robertson SL; Garcia J; Beingasser J; McClane BA; Uzal FA Infect Immun; 2014 Nov; 82(11):4778-88. PubMed ID: 25156725 [TBL] [Abstract][Full Text] [Related]